This website is intended for Medical Professionals only. By using this site you confirm that you are a healthcare professional.

News
Maar Dora Francesco Carelli, University of Milan (12 Dec 2019)
Anastrozole reduces breast cancer rates for ... Queen Mary University of London-led research finds Anastrozole ... (10 Dec 2019)
Taking fish oil tablets for four weeks ... Fish oil supplements can significantly improve ‘night vision’, ... (12 Dec 2019)
Give a Gift this Christmas which gives back The story of medicine is the story of civilization, from an ... (12 Dec 2019)
Elderly people should aim to keep up step ... Just two weeks of inactivity increases body fat and harms ... (12 Dec 2019)
×

Warning

JUser: :_load: Unable to load user with ID: 5232
Thursday, 28 February 2019 20:47

Could Medical Marijuana Help Grandma and Grandpa with Their Ailments? Featured

Rate this item
(0 votes)

New Study Shows It May Be Safe and Effective for Symptoms of Chronic Disease

 Medical marijuana may bring relief to older people who have symptoms like pain, sleep disorders or anxiety due to chronic conditions including amyotrophic lateral sclerosis, Parkinson’s disease, neuropathy, spinal cord damage and multiple sclerosis, according to a preliminary study that will be presented at the American Academy of Neurology’s 71st Annual Meeting in Philadelphia. The study not only found medical marijuana may be safe and effective, it also found that one-third of participants reduced their use of opioids. However, the study was retrospective and relied on participants reporting whether they experienced symptom relief, so it is possible that the placebo effect may have played a role. Additional randomized, placebo-controlled studies are needed.

According to the Centers for Disease Control and Prevention, approximately 80 percent of older adults have at least one chronic health condition.

“With legalization in many states, medical marijuana has become a popular treatment option among people with chronic diseases and disorders, yet there is limited research, especially in older people,” said study author Laszlo Mechtler, MD, of Dent Neurologic Institute in Buffalo, N.Y., and a Fellow of the American Academy of Neurology. “Our findings are promising and can help fuel further research into medical marijuana as an additional option for this group of people who often have chronic conditions.”

The study involved 204 people with an average age of 81 who were enrolled in New York State’s Medical Marijuana Program. Participants took various ratios of tetrahydrocannabinol (THC) to cannabidiol (CBD), the main active chemicals in medical marijuana, for an average of four months and had regular checkups. The medical marijuana was taken by mouth as a liquid extract tincture, capsule or in an electronic vaporizer.

Initially, 34 percent of participants had side effects from the medical marijuana. After an adjustment in dosage, only 21 percent reported side effects. The most common side effects were sleepiness in 13 percent of patients, balance problems in 7 percent and gastrointestinal disturbances in 7 percent. Three percent of the participants stopped taking the medical marijuana due to the side effects. Researchers said a ratio of one-to-one THC to CBD was the most common ratio among people who reported no side effects.

Researchers found that 69 percent of participants experienced some symptom relief. Of those, the most common conditions that improved were pain with 49 percent experiencing relief, sleep symptoms with 18 percent experiencing relief, neuropathy improving in 15 percent and anxiety improving in 10 percent.

Opioid pain medication was reduced in 32 percent of participants.

“Our findings show that medical marijuana is well-tolerated in people age 75 and older and may improve symptoms like chronic pain and anxiety,” said Mechtler. “Future research should focus on symptoms like sleepiness and balance problems, as well as efficacy and optimal dosing.”

Source Newsroom: American Academy of Neurology (AAN)

Read 711 times

Latest news

Highlights

  • Nescafé 3 in1 LifeCycle HEROES return from South Asia

    Donations for Nescafé 3in1 LifeCycle Challenge 2019 can be sent via sms: 5061 7370 = €2.33; 5061 8920 = €6.99; 5061 9229 = €11.65; or via a call to 5160 2020 = €10, 5170 2005 = €15; and 5180 2006 = €25. Bank details are Swift code VALLMTMT, IBAN number MT 18 VALL 22013000000014814521017, Bank name Bank of Valletta, Account number 14814521017.

    Read more...
  • Give a Gift this Christmas which gives back

    The story of medicine is the story of civilization, from an ancient craft of primitive magic and religion to the sophisticated field of science and technology of today.

    Read more...

Join

Connect with other Medical Professionals on fb in a closed facebook group

Login

Top
We use cookies to improve our website. By continuing to use this website, you are giving consent to cookies being used. More details…